Building More Resilient API Supply Chains

Safe, secure and reliable supply lines for key medicines is one of pharma's top priorities. However, as recent reports about shortages of active pharmaceutical ingredients (APIs) impacting on the supply of key medicines show, there are lessons to be learned to ensure optimum supply chain security.

As we have discussed in previous blogs, de-risking the supply chain is crucial to mitigate the impact from both foreseeable and unforeseeable events.

From a risk management standpoint, it is important to pursue a dualistic, longer term supply strategy that embraces cost control and supply reliability/diversity to improve the integrity and resilience of international supply chains.

So, where should companies begin to develop a more resilient API supply chain? Here are some more key tips to help de-risk.